The In Vitro Impact of Glycyrrhizic Acid on CD4+ T Lymphocytes through OX40 Receptor in the Patients with Allergic Rhinitis
- 79 Downloads
Glycyrrhizic acid (GA), the major bioactive component of glycyrrhiza, possesses anti-inflammatory, anti-allergic, and immunomodulatory activities. This study aimed to investigate the in vitro anti-allergic effect of GA through the OX40 receptor in patients with allergic rhinitis. Purified naive CD4+ T cells of patients with allergic rhinitis (n = 12) were activated with anti-CD3/anti-CD28 with and without anti-OX40 agonist mAbs and then treated with 50, 100, and 200 μM GA and 0.1 μM dexamethasone. Cells were incubated (72 h) to measure cell proliferation. Expression of OX40 in anti-OX40 mAb stimulated CD4+ T cells was evaluated by flow cytometry. mRNA expression of the OX40 receptor and T-bet, GATA-3, and forkhead box P3 (FoxP3) transcriptional factors were measured by a quantitative polymerase chain reaction. The levels of interleukin (IL)-4, IL-10, and interferon-γ (IFN-γ) were also measured. GA inhibited significantly the augmented T cell proliferation induced with anti-OX40 mAb. Protein and gene expression of OX40 was also decreased significantly. Dexamethasone and GA inhibited T-bet and GATA-3 genes expression, but this inhibition was only significant for GATA-3. In contrast, enhanced gene expression of FoxP3 was seen using 200 μM GA and dexamethasone. The levels of IL-4, IL-10, and IFN-γ decreased after treatment with both dexamethasone and GA, but the ratio of IFN-γ/IL-4 (Th1/Th2 balance) increased significantly due to 200 μM GA treatment. This study suggests that GA may have a therapeutic effect on allergic rhinitis, partly by modulation of the Th1/Th2 balance through suppression of OX40 and increasing the activity of regulatory T cells.
KEY WORDSglycyrrhizic acid OX40 receptor allergic rhinitis CD4+ T cells
This work was supported by grant 394902 from Isfahan University of Medical Sciences.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no competing interests.
All procedures performed in studies involving human participants were in accordance with the Ethics Committee of Isfahan University of Medical Sciences (Code of Ethics: IR.MUI.REC.1394.3.902) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Jaruvongvanich, V., P. Mongkolpathumrat, H. Chantaphakul, and J. Klaewsongkram. 2016. Extranasal symptoms of allergic rhinitis are difficult to treat and affect quality of life. Allergology International 65 (2): 199–203.Google Scholar
- 4.Shaaban, R., M. Zureik, D. Soussan, C. Neukirch, J. Heinrich, J. Sunyer, M. Wjst, I. Cerveri, I. Pin, J. Bousquet, D. Jarvis, P.G. Burney, F. Neukirch, and B. Leynaert. 2008. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 372 (9643): 1049–1057.CrossRefPubMedGoogle Scholar
- 18.Isbrucker, R.A., and G.A. Burdock. 2006. Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regulatory Toxicology and Pharmacology 46 (3): 167–192.CrossRefPubMedGoogle Scholar
- 19.Nesar, A., M. Khalid, A. Juber, M. Mujahid, Badruddin, M. Anuradha, and K. Nazma. 2016. Glycyrrhiza glabra: for traditional uses and pharmacological actions. Advanced Journal of Pharmacie and Life Science Research 4 (2): 23–32.Google Scholar
- 23.Khazraei-Moradian, Soheila, Mazdak Ganjalikhani-Hakemi, Alireza Andalib, Reza Yazdani, Javad Arasteh, and Gholam Ali Kardar. 2017. The effect of licorice protein fractions on proliferation and apoptosis of gastrointestinal cancer cell lines. Nutrition and Cancer 69 (2): 330–339.CrossRefPubMedGoogle Scholar
- 25.Alekperov, Urkhan K. 2002. Plant antimutagens and their mixtures in inhibition of genotoxic effects of xenobiotics and aging processes. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) 11: S8–S11.Google Scholar
- 29.Kaur, Rajandeep, Harpreet Kaur, and Ajaib Singh Dhindsa. 2013. Glycyrrhiza glabra: A phytopharmacological review. International Journal of Pharmaceutical Sciences and Research 4 (7): 2470.Google Scholar
- 34.Dousti, M., M.H. Ramchandani, A. Barkhordarian, S. Danaei, and F. Chiappelli. 2012. Evidence-based traditional Persian medicine. In Evidence-based practice in complementary and alternative medicine, 79–96. Berlin, Heidelberg: Springer.Google Scholar
- 37.Yang, R., B.C. Yuan, Y.S. Ma, S. Zhou, and Y. Liu. 2017. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharmaceutical Biology 55 (1): 5–18. Google Scholar
- 43.Kim, Seung-Hyung, Jung-hee Hong, Ji-Eun Lee, and Young-Cheol Lee. 2017. 18β-Glycyrrhetinic acid, the major bioactive component of glycyrrhizae radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model. Environmental Toxicology and Pharmacology 52: 99–113.CrossRefPubMedGoogle Scholar
- 44.Yang, Nan, Sangita Patil, Jian Zhuge, Ming-Chun Wen, Jayaprakasam Bolleddula, Srinivasulu Doddaga, Joseph Goldfarb, Hugh A. Sampson, and Xiu-Min Li. 2013. Glycyrrhiza uralensis flavonoids present in anti-asthma formula, ASHMITM, inhibit memory Th2 responses in vitro and in vivo. Phytotherapy Research 27 (9): 1381–1391.CrossRefPubMedGoogle Scholar
- 46.Patil, S.P., W.J. Ji, A. Singha, D.E. Hendricks, P.J. Busse, H.A. Sampson, J.P. Wisnivesky, and X. Li. 2010. In vitro immunomodulatory effect of ASHMI (anti-asthma herbal medicine intervention) on PBMCs from asthmatics. Journal of Allergy and Clinical Immunology 125 (2): AB198.CrossRefGoogle Scholar
- 47.Chunhua, Ma, Zhanqiang Ma, Xiao-lin Liao, Jiping Liu, Qiang Fu, and Shiping Ma. 2013. Immunoregulatory effects of glycyrrhizic acid exerts anti-asthmatic effects via modulation of Th1/Th2 cytokines and enhancement of CD4+ CD25+ Foxp3+ regulatory T cells in ovalbumin-sensitized mice. Journal of Ethnopharmacology 148 (3): 755–762.CrossRefGoogle Scholar